ATORVASTATIN CALCIUM
- Product NDC
- 50090-6506
- 11-digit product format
- 500906506
- Labeler code
- 50090
- Product ID
- 50090-6506_318deb0c-d033-4439-bf62-0bacfd6c2d86
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA090548
- Marketing category
- ANDA
- Marketing start
- 2021-08-01
- Substance
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE
- Active strength
- 80 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| YRZ789OWMI | ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE | 1040350-07-9 | ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6506-0 | 50090650600 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-6506-0) | 2023-05-30 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| ATORVASTATIN CALCIUM | A-S Medication Solutions | 2023-07-21 | HUMAN PRESCRIPTION DRUG LABEL | 2 |